Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Analysis of Liquidity Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Liquidity Ratios (Summary)

Medtronic PLC, liquidity ratios (quarterly data)

Microsoft Excel
Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020
Current ratio
Quick ratio
Cash ratio

Based on: 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).


The liquidity position, as indicated by the current, quick, and cash ratios, exhibits fluctuations over the observed period. Generally, the ratios demonstrate a strengthening trend through much of 2021, followed by a period of decline, and then some stabilization with further fluctuations. A closer examination of each ratio reveals specific patterns.

Current Ratio
The current ratio generally increased from 1.87 in July 2020 to a peak of 2.91 in October 2021. A subsequent decline was observed, reaching a low of 1.58 in July 2022. The ratio then recovered to 2.54 by January 2026, with intermediate fluctuations. The most recent value, 2.54, suggests a healthy ability to cover short-term liabilities with short-term assets, though it is slightly lower than the peak observed in late 2021. The period from October 2021 to July 2022 shows the most significant decrease.
Quick Ratio
The quick ratio follows a similar pattern to the current ratio, increasing from 1.37 in July 2020 to 2.07 in October 2021. It then decreased to a low of 1.01 in July 2022. A recovery is evident, reaching 1.55 in January 2026. The quick ratio consistently remains below the current ratio, as expected, due to the exclusion of inventory from its calculation. The decline from October 2021 to July 2022 is particularly pronounced, indicating a weakening in the ability to meet short-term obligations with the most liquid assets.
Cash Ratio
The cash ratio also demonstrates an initial increase, moving from 0.99 in July 2020 to 1.37 in October 2021. A subsequent decline is observed, reaching a low of 0.63 in July 2022. The ratio then recovers to 0.88 in January 2026, though it remains below the levels seen in late 2021. This ratio consistently represents the smallest value among the three, reflecting the conservative nature of its calculation, focusing solely on cash and cash equivalents. The period between October 2021 and July 2022 shows a substantial decrease in the proportion of current assets held as cash.

Overall, the observed trends suggest a period of strengthening liquidity through 2021, followed by a period of reduced liquidity in 2022. The ratios have shown some recovery in subsequent periods, but have not consistently returned to the levels observed in late 2021. The consistent relationships between the ratios – with the quick ratio below the current ratio and the cash ratio being the lowest – are maintained throughout the period.


Current Ratio

Medtronic PLC, current ratio calculation (quarterly data)

Microsoft Excel
Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020
Selected Financial Data (US$ in millions)
Current assets
Current liabilities
Liquidity Ratio
Current ratio1
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).

1 Q3 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The current ratio exhibited considerable fluctuation over the observed period, spanning from July 2020 to July 2025. Initially, the ratio demonstrated an increasing trend, peaking in October 2021, before experiencing a decline and subsequent recovery. A general observation suggests a tendency towards stabilization in the later periods, though continued variability is present.

Initial Increasing Trend (July 2020 – October 2021)
The current ratio began at 1.87 in July 2020 and rose to 2.16 by October 2020, indicating improving liquidity. This upward momentum continued, reaching a high of 2.91 in October 2021. This period suggests a strengthening ability to cover short-term obligations with short-term assets.
Subsequent Decline and Recovery (January 2022 – April 2023)
Following the peak, the current ratio decreased to 1.86 in January 2022, and further to a low of 1.58 in April 2022. A recovery commenced, with the ratio reaching 2.39 in April 2023. This fluctuation could be attributed to changes in working capital management, seasonal variations in sales, or alterations in short-term financing strategies.
Recent Fluctuations and Stabilization Attempts (July 2023 – July 2025)
From July 2023 through July 2025, the current ratio continued to fluctuate, ranging from 2.29 to 2.54. While there isn't a clear directional trend, the values generally remained above 2.0, suggesting a reasonably healthy liquidity position. The ratio ended at 2.54 in July 2025, indicating a slight increase from the prior period.
Overall Observations
The observed variations in the current ratio suggest dynamic working capital management. While the company generally maintains a current ratio above 1.5, the fluctuations warrant continued monitoring. Periods of lower ratios may necessitate closer attention to cash flow and short-term debt obligations. The recent stabilization, albeit with continued variability, could indicate a maturing liquidity management approach.

Quick Ratio

Medtronic PLC, quick ratio calculation (quarterly data)

Microsoft Excel
Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020
Selected Financial Data (US$ in millions)
Cash and cash equivalents
Investments
Accounts receivable, less allowances and credit losses
Total quick assets
 
Current liabilities
Liquidity Ratio
Quick ratio1
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).

1 Q3 2026 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The quick ratio for the analyzed period demonstrates considerable fluctuation, generally trending downwards from mid-2021 before stabilizing and showing a slight increase towards the end of the observed timeframe. Initial values indicate a strong short-term liquidity position, which gradually diminishes before a partial recovery.

Overall Trend
The quick ratio began at 1.37 and peaked at 2.07 in late 2021. A subsequent decline was observed, reaching a low of 1.01 in mid-2022. From that point, the ratio exhibited a degree of volatility, generally remaining between 1.17 and 1.55 over the final reporting periods. The most recent value, 1.55, suggests an improvement in the short-term liquidity position compared to the low point in 2022, but remains below the peak observed earlier in the period.
Initial Period (July 2020 – October 2021)
The initial period shows a consistent strengthening of the quick ratio. It increased from 1.37 to 1.63, then to 1.58, and peaked at 2.07. This indicates a growing ability to meet short-term obligations with highly liquid assets during this timeframe. Both quick assets and current liabilities experienced changes, but the increase in quick assets outpaced the increase in current liabilities.
Subsequent Decline (January 2022 – April 2023)
Following the peak, the quick ratio experienced a significant decline. It fell to 1.87, 1.30, and then to a low of 1.01. This suggests a weakening of the company’s short-term liquidity position. The decrease was driven by a combination of decreasing quick assets and increasing current liabilities. The most substantial drop occurred between January 2022 and April 2022.
Recent Stabilization and Slight Improvement (July 2023 – January 2026)
From July 2023 onwards, the quick ratio demonstrated more stability, fluctuating between 1.17 and 1.55. A slight upward trend is visible in the latter part of the period, culminating in a ratio of 1.55. This suggests that the company has taken steps to address the liquidity concerns observed earlier, or that external factors have contributed to the improvement. The most recent value indicates a return to a more comfortable liquidity position, though not as strong as that seen in late 2021.

The observed fluctuations in the quick ratio warrant continued monitoring to assess the sustainability of the recent improvement and to identify any potential future liquidity risks.


Cash Ratio

Medtronic PLC, cash ratio calculation (quarterly data)

Microsoft Excel
Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020
Selected Financial Data (US$ in millions)
Cash and cash equivalents
Investments
Total cash assets
 
Current liabilities
Liquidity Ratio
Cash ratio1
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).

1 Q3 2026 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The cash ratio for the analyzed period demonstrates fluctuations, generally exhibiting a decreasing trend over the long term, though with notable interim increases. Initially, the ratio begins at 0.99 and experiences improvement, peaking at 1.37 before a sustained decline. Recent quarters show some stabilization, but remain below the initial values.

Initial Period (Jul 31, 2020 – Oct 29, 2021)
The cash ratio demonstrates a strengthening liquidity position during this timeframe. Starting at 0.99, it increases to 1.18, then remains relatively stable around 1.17-1.37. This suggests an increasing ability to cover current liabilities with immediately available cash.
Subsequent Decline (Jan 28, 2022 – Apr 28, 2023)
A clear downward trend emerges. The ratio decreases from 1.26 to 0.88. This indicates a weakening in the company’s immediate liquidity, potentially due to increases in current liabilities or decreases in total cash assets, or a combination of both. The lowest point in the observed period is reached at 0.63.
Recent Stabilization (Jul 28, 2023 – Jan 23, 2026)
The ratio fluctuates between 0.70 and 0.88 in the most recent quarters. While still below the levels observed in the initial period, this suggests a potential stabilization of the company’s immediate liquidity position. The final observed value is 0.88.
Total Cash Assets
Total cash assets initially increased from US$13,012 million to US$14,639 million, then decreased significantly to US$7,876 million before fluctuating between approximately US$7,734 million and US$11,137 million. The most recent value is US$8,383 million.
Current Liabilities
Current liabilities generally increased over the period, starting at US$13,086 million and peaking at US$14,465 million. There were interim decreases, but the overall trend is upward, contributing to the observed decline in the cash ratio. The most recent value is US$9,495 million.

The observed fluctuations in the cash ratio warrant further investigation to understand the underlying drivers. A sustained decline in this ratio could indicate increasing liquidity risk, while stabilization suggests a potential improvement in short-term financial health.